What is visceral fat, and why does it matter more than BMI?
The short answer
Visceral fat sits inside the abdomen around the liver, pancreas and intestines. Unlike the fat you can pinch, it releases inflammatory signals and fatty acids that drive insulin resistance, fatty liver and heart disease. A man with a normal BMI can still carry too much. A DEXA scan or waist measurement shows it.
Medical review pending. A clinician has not reviewed this article yet. Read it as general information, not medical advice.
Vane editorial teamPublished 5 min read
The most consequential fat in your body is the fat you cannot pinch. It sits behind the abdominal wall, wraps your liver, pancreas, and intestines, and signals to the rest of your physiology in ways that subcutaneous fat does not. A man with low visible body fat can still carry dangerous amounts of it.
This is the fat that BMI misses, the scale misses, and the mirror misses. It is also the fat that most closely tracks future cardiovascular and metabolic disease.
What is visceral fat?
Visceral adipose tissue (VAT) is the fat stored inside the abdominal cavity, surrounding the internal organs. It is distinct from subcutaneous fat, the soft layer under the skin that you can pinch. The two tissues behave like different organs. They have different cell sizes, different blood supplies, different hormonal outputs, and different metabolic consequences.
Subcutaneous fat is largely inert. It stores energy and stays mostly out of the way of systemic metabolism. Visceral fat is metabolically active. It releases inflammatory cytokines (TNF-alpha, IL-6), free fatty acids directly into the portal circulation, and adipokines that disrupt insulin signaling.
The result: visceral fat drives metabolic disease in ways that subcutaneous fat does not, independent of total body weight.
Why visceral fat matters more than BMI
A 6-foot, 195-pound man at a BMI of 26.4 is "overweight" by the chart. He could be a lean recreational athlete with normal labs, or he could be a thin-skinned but visceral-heavy man with insulin resistance and a fatty liver. BMI does not distinguish the two.
The clinical phenotype that matters is normal-weight central obesity, sometimes called "TOFI" (thin outside, fat inside). Roughly 20% of normal-BMI men have elevated visceral fat. They look fine. Their labs say otherwise.
The independent risk pattern is consistent in the literature:
- Visceral fat correlates more tightly with cardiovascular events than BMI.
- It predicts type 2 diabetes onset better than total body fat.
- It is the strongest fat-related driver of non-alcoholic fatty liver disease.
- It tracks with all-cause mortality more reliably than weight.
A man can lose total weight and not move his visceral fat. He can also lose visceral fat without much change in the scale. The two trajectories are not the same trajectory.
How is visceral fat measured?
Several methods, with different tradeoffs:
- DEXA scan with VAT estimation: a common clinical tool. Accurate, fast (under 10 minutes), low radiation. Gives a direct VAT mass in grams. Often the most practical clinical method.
- MRI: the research gold standard. Most accurate, no radiation, but expensive and slow.
- CT abdominal slice: accurate, but uses ionizing radiation. Reserved for specific clinical indications.
- Bioelectrical impedance (BIA): cheap, available on consumer scales, but variable in accuracy. Useful for tracking trend in the same person, not for absolute number.
- Waist circumference: a surprisingly decent proxy. A waist above 40 inches in a man correlates with elevated visceral fat in most cases. A waist-to-height ratio above 0.5 is the threshold most often used.
- Waist-to-hip ratio: above 0.9 in men is a useful flag.
A DEXA at baseline is the cleaner start. For a man trying to manage cost, a tape measure at the umbilicus and a stack of consistent labs gets you 80% of the answer.
What is a normal visceral fat number?
Commonly used DEXA VAT mass thresholds:
- Under 500 g: low and healthy.
- 500 to 1,000 g: typical for a metabolically healthy adult man.
- 1,000 to 1,500 g: elevated. Warrants attention.
- Above 1,500 g: high. Strongly associated with metabolic disease.
- Above 2,000 g: very high. The phenotype most aggressively driving cardiometabolic risk.
Cutoffs vary slightly by reference lab and machine. The trend matters more than the absolute number in many cases.
What actually moves visceral fat
The lever-by-lever evidence is reasonably consistent:
- Sustained calorie deficit. Even modest deficits preferentially mobilize visceral fat early. The first 5% to 10% of body weight lost on most diets is disproportionately visceral.
- Resistance training. Three sessions a week, progressive. Resistance training reduces visceral fat even when total weight is stable.
- GLP-1 medications. The trials show a larger visceral-to-subcutaneous reduction ratio than equivalent diet-only weight loss in many patients.
- Sleep duration. Sleeping under 6 hours consistently increases visceral fat accumulation independent of diet.
- Alcohol reduction. Alcohol calories preferentially deposit as visceral fat. The effect is dose-dependent.
- Fiber intake. Higher soluble fiber correlates with lower visceral fat in observational and intervention studies.
- Stress management. Cortisol drives central adiposity. The link is real, even if "manage your stress" is hard to operationalize.
The practical playbook is in How to lose visceral fat. The short version: the levers compound, and running them in parallel for 12 to 24 weeks can move visceral fat meaningfully, even on the same body weight.
How visceral fat connects to other markers
Visceral fat is not a standalone problem. It is the upstream variable that drives several downstream markers:
- It elevates ApoB and shifts the lipid profile toward small-dense LDL.
- It raises fasting insulin and pushes A1c upward over time.
- It increases hs-CRP and other inflammatory markers.
- It drops total and free testosterone, both via aromatization and via insulin-driven SHBG changes.
Treating the visceral fat often improves all of these at once. Treating the downstream markers without addressing the visceral driver is a slower road.
Where this lands
Visceral fat is the most clinically useful body composition variable a man over 35 can track. It explains the gap between "I look fine" and "my labs say otherwise." It moves with effort. It is the variable that responds to the levers covered here: training, sleep, alcohol reduction, and (when indicated) a GLP-1 medicine.
A DEXA at baseline and another at 12 weeks tells you more about your metabolic trajectory than a year of bathroom scale data. If you have never measured it, that is the first lab worth ordering.
Sources
Where this comes from
Sources are added during medical review.
Next steps
Where to go from here
- ProgramWeightBranded GLP-1s only, with a plan that works to preserve muscle. Weight plan: $99 a month.See the Weight program
- Rx conciergeCheck a priceFind the cheapest legal way to fill a prescription. Vane earns nothing from any pharmacy, coupon or manufacturer.Check a price
Clinical care is not live yet. Get early access to hear when it opens in your state.
General information, not medical advice. A licensed clinician decides what is right for you.